However, the distribution of IDC-P among the other molecular classes does not appear to differ significantly from that of “conventional” prostate cancer, suggesting that while the SPOP mutation is strongly associated with IDC-P cases, additional factors contribute to the observed molecular heterogeneity [35]. The gene discussed is SPOP; the disease is prostate cancer.